Table 4.
Incidence and Concentration of Herpes Zoster (HZ) Among Patients With and Without Recent Care For Cancer, HIV Infection, or Transplantation*
| Patient Group | Person-Years | Cases | Rate per 1,000 Person-Years† (95% CI) | % of HZ Patients† |
|---|---|---|---|---|
| All ages | ||||
| Cancer, HIV, or transplantation | 82,847 | 865 | 10.3 (9.7, 11.0) | 8.7 |
| No cancer, HIV, or transplantation | 2,331,550 | 8,287 | 3.0 (2.9, 3.0) | 91.3 |
| Overall | 2,414,397 | 9,152 | 3.2 (3.1, 3.2) | 100.0 |
| Age 0 to 49 | ||||
| Cancer, HIV, or transplantation | 20,001 | 127 | 6.2 (5.2, 7.4) | 4.3 |
| No cancer, HIV, or transplantation | 1,440,531 | 2,610 | 1.7 (1.6, 1.8) | 95.7 |
| Overall | 1,460,532 | 2,737 | 1.7 (1.7, 1.8) | 100.0 |
| Age ≥50 | ||||
| Cancer, HIV, or transplantation | 62,845 | 738 | 12.2 (11.4, 13.1) | 11.7 |
| No cancer, HIV, or transplantation | 891,020 | 5,677 | 6.6 (6.5, 6.8) | 88.3 |
| Overall | 953,865 | 6,415 | 7.0 (6.8, 7.2) | 100.0 |
As measured by the presence or absence of a diagnosis, procedure, or drug code for cancer, HIV infection, or transplantation (solid organ, bone marrow, or stem cell) during the 180 days prior to a physician diagnosis of herpes zoster.
Overall rates and percentages age- and sex-adjusted to the 2000 U.S. population.